Categories
Gujarat Themis Biosyn Limited — Important, 23-04-2026: Agreements
23-04-2026 · 11:40 pm
Gujarat Themis Biosyn (GTBL) acquired Sanofi's portfolio of 13 anti-TB and anti-infective brands for €158 million cash. This move strengthens GTBL's global generics platform and expands its international footprint across 55+ countries, leveraging existing API capabilities.
No comments yet. Be the first to comment!